why choose us

First received: October 18, 2023

Clinical Trial: Ponatinib in CML Patients in Chronic Phase

Study Status: Completed

Recruit Status: RECRUITING

Condition: Chronic Myeloid Leukemia, Chronic Phase

Study Type: OBSERVATIONAL


Official Title: Ponatinib in cHronic myelOid LEukemia patieNts In Chronic phaSe: the PHOENICS Protocol

Brief Summary: The goal of this retrospective observational study is to evaluate any possible association between plasma concentrations of ponatinib and its pharmacodynamics (efficacy/tolerability) in patients affected by chronic myeloid leukemia in chronic phase (CML-CP).In particular, the aims of the study will be:primary aim: to investigate the relationships (if any) between plasma concentrations and activity/toxicity of ponatinib in a population of CML-CP patients enrolled in several Italian hematological…

Read more